Johns Hopkins Endorses Vitamin E for Age-Related Macular Degeneration
Washington
DC, 23 January 2004
Source: Foods for the Future
Supplementation
containing Vitamin E "provides an exciting preventive measure" for
age-related macular degeneration, a professor of ophthalmology at
Johns Hopkins University has concluded after taking part in a major
ongoing research effort.
"There
are no other proven options for early intervention," Dr. Susan Bressler
says in the coming February edition of the Johns Hopkins medical
letter, Health After 50.
Vitamin
E intake of 400 milligrams, together with Vitamin C, beta carotene,
and small amounts of zinc and copper oxides, reduces the likelihood
of disease progression by 25 percent in patients with intermediate
age-related macular degeneration, or AMD, the research has determined.
"Supplementation
with this formulation also reduced the risk of vision loss by 19
percent over five years in these patients," the Johns Hopkins publication
reported.
Until
now, there has been no proven treatment to slow the progression
of disease and possible vision loss in people with dry AMD, the
most common form of the condition, Dr. Bressler said.
Major
clinical trials of the Vitamin E and other supplementation started
two years ago, and a follow-up report was published recently in
the Archives of Ophthalmology. Researchers concluded in the
report that "if every American with intermediate AMD took these
vitamins and minerals, more than 300,000 people could avoid AMD-associated
vision loss over the next five years."
More
than 1.6 million Americans over age 60 have age-related macular
degeneration, which is the most common cause of visual impairment
and blindness in the US.
Source
Foods
for the Future.
|